"In order to create the most beautiful results, you have to be able to see it from an artistic perspective. Surgical skills are essential but they are not enough. There is an aesthetic that cannot be taught. It has to be innate."
20635 Abbey Woods Ct N, Suite 202
Frankfort, IL 60423

Blog


Latisse & the Path to Sexy Lashes

Like many drugs developed in recent years, Latisse made its way to the market inadvertently.  The hot new eyelash enhancer was born out of a group of popular medications called topical prostaglandins, drugs frequently used to decrease intra-ocular pressure in glaucoma patients.

What optometrists labeled a ‘complication’ or side effect of using these topical  agents was “hypertrichosis,” a condition characterized by darkening, thickening, and lengthening of the eyelashes.   

 Allergan offered the topical prostaglandin Lumigan in 2001, a drug that contained the active ingredient bimatoprost. Two important precursors to Latisse occurred after the FDA gave clearance for Lumigan.

Jan Marini Skin Research Inc had over $2 million worth of product seized by the Food and Drug Administration.  The product, Age Intervention Eyelash, evidently contained bimatoprost, which was unapproved for cosmetic use at the time. Allergan later filed a patent infringement suit against Jan Marini and several other companies that had tried to market bimatoprost in their eyelash enhancing drugs.

Some doctors started prescribing Lumigan off-label to enhance eyelashes.  Knowing the desirable side effects it could produce. But Lumigan wasn’t formulated for cosmetic use and many believed more research was needed to confirm the safety of topical prostaglandins for cosmetic use.  

Clinical trials and further research is exactly what Alllergan Inc did.  278 healthy adults with minimal to moderate eyelash prominence applied bimatoprost or a placebo to their lash line.  The results were favorable; researchers observed that the average patient’s eyelashes were 25 percent longer, 106 percent fuller, and 18 percent darker, while only 3.6 percent experienced itchy eyes and redness, and only 2.9 percent experienced skin hyperpigmentation.  

Latisse received FDA approval late last year for the treatment of ‘inadequate’ eyelashes.  Allergan now owns the patent on use of bimatoprost for eyelash enhancement.

For more information on Latisse in Illinois or Indiana, contact Plastic Surgery Experts.

Leave a Reply



Home | Dr. Dreyfuss | Dr. Gelman | Contact Us | Questions and Answers | Map | Privacy Policy | Breast Photo Gallery | Body Photo Gallery | Face Photo Gallery | Blog
Breast Augmentation | Breast Lift | Breast Reduction | Facelift | Rhinoplasty | Post-Bariatric | Non-Surgical | Sitemap

Plastic Surgery Experts, Dr. David Dreyfus and Dr. Jack Gelman specialize in cosmetic and recostructive plastic surgery, facelift, eyelid surgery,
breast augmentation, breast lift, tummy tuck, liposuciton, injectable fillers and Botox®.

Serving greater Chicago, Illinois and Northwest Indiana, including, Frankfort, Hazel Crest, Homer Glen, Mokena, New Lenox, Orland Park, Palos Park, Tinley Park, Illinois, Munster, Indiana and surrounding areas.

20635 Abbey Woods Ct. North Ste. 202., Frankfort, IL 60423 • (815) 806-9400
701 Superior Avenue, Suite 317, Munster, In 46321 • (219) 934-9782

Copyright © 2007 Plastic Surgery Specialists Inc. All Rights Reserved.

Site by